KALV — KALVISTA PHARMACEUTICALS INC

Ownership history in Caption Management, LLC  ·  13 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in KALVISTA PHARMACEUTICALS INC (KALV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.08% (2025 Q3)
Avg. % of fund
0.04%
First filed
2022 Q3
Last filed
2025 Q4
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 117,907 -746,693 -86.4% 0.01% $1.9M $16.15
2025 Q3 ADDED 864,600 +723,178 +511.4% 0.08% $10.5M $12.18
2025 Q3 REDUCED 141,422 -440,178 -75.7% 0.01% $1.7M $12.18
2025 Q3 ADDED 581,600 +131,600 +29.2% 0.06% $7.1M $12.18
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    KALV price (monthly, adj. close)

Other funds also holding KALV

As of 2025 Q4 — sorted by position size

SILVERARC CAPITAL MANAGEMENT, LLC 3Y 5.44% VR Adviser, LLC 3Y 5.37% Elmind Capital, LP 3.82% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 3.65% GREAT POINT PARTNERS LLC 3Y 7Y 3.59% Parkman Healthcare Partners LLC 3Y 2.72% Octagon Capital Advisors LP 3Y 2.5% Frazier Life Sciences Management, L.P. 3Y 2.19% Kynam Capital Management, LP 3Y 1.87% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.58%
← Back to Caption Management, LLC Holdings